Delivery Order SPE2DB25D3404-SPE2DB25FUNXS
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 200-unit vials of BOTOX, valued at $3,419.20, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and is being fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $10,257.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 200-unit vials of BOTOX on June 27, 2025, with completion targeted for July 21, 2025. This non-competitive award, issued from the company's Conshohocken, Pennsylvania location, represents a child order under AmerisourceBergen's broader pharmaceutical supply agreements with DLA. The award reflects routine medical procurement for federal healthcare systems, leveraging the...
- The Defense Logistics Agency awarded a $5,128.74 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 200-unit vials of BOTOX, with an ultimate completion date of August 4, 2025. This is a non-set-aside, competitively awarded delivery order with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at $1,722.72 to AmerisourceBergen Drug Corp for 100-unit vials of BOTOX on July 10, 2025, with an ultimate completion date of July 31, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp...
- The Defense Logistics Agency awarded a $8,547.90 delivery order to AmerisourceBergen Drug Corp for BOTOX 200 Unit Vials on June 18, 2025, with an ultimate completion date of July 11, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded to the prime contractor at its Conshohocken, Pennsylvania location. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $10,336.32 to AmerisourceBergen Drug Corp for 100-unit vials of BOTOX on May 27, 2025, with completion targeted for June 17, 2025. This is a firm fixed-price delivery order under a non-competitive set-aside arrangement, performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor in the federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Botox 100 unit vials valued at $10,336.32. This firm fixed-price delivery order, with a completion date of August 11, 2025, will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The contract was awarded without a set-aside designation, indicating open competition. This delivery order is a child contract issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a $3,011.25 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 200-unit vials of Botox, with an ultimate completion date of August 19, 2025. The contract, which was competitively awarded with no set-aside designation, is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 200-unit vials of BOTOX with a ceiling value of $230,793.30. This firm fixed-price, competitively awarded contract was executed on July 25, 2025, with an ultimate completion date of August 15, 2025. The award carries no set-aside designation and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of BOTOX 100 unit vials with a ceiling value of $1,722.72. This firm fixed price delivery order represents a non-set-aside competitive award with an ultimate completion date of August 25, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- SPE2DB25D3404Indefinite Delivery Contract
- SPE2DB25D3404-SPE2DB25FUNXSDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100-unit vials of BOTOX, valued at $4,306.80, on June 18, 2025, with an ultimate completion date of July 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The parent IDC vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies globally to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This specific delivery order for BOTOX reflects the company's capability to fulfill specialized pharmaceutical needs within the broader military medical supply chain, consistent with its established portfolio of brand-name medications and medical commodities delivered under the DLA Troop Support Medical contract framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 6/18/25 |